# Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study

> **NCT05782101** · — · COMPLETED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 30 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia; Retinopathy of Prematurity

## Interventions

- **DIAGNOSTIC_TEST:** Integrated proteomic HPLC-ESI-MS analysis of salivary peptides

## Key facts

- **NCT ID:** NCT05782101
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-17
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05782101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05782101, "Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05782101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
